The AST has endorsed and signed on to a joint Patient/Provider letter to the Congressional "Super Committee" Joint Deficit Budget Reduction Committee. The joint sign-on letter is in support of continuing the Medicare Part D classes of clinical concern policy that requires plans to cover "all or substantially all drugs" for six critical lifesaving drug classes. This policy has successfully protected patients of vulnerable populations who need access to important, non-interchangeable medications. It is intended to ensure additional protections beyond the statutory minimum of two drugs per therapeutic class.

Read the letter